Primary analysis of the registration-intended cohort of patients with anti–PD-1–failed melanoma from the IGNYTE trial of RP1 plus nivolumab, including clinical subgroup and initial biomarker data

作者：E. Muñoz Couselo, C. Robert, Praveen K. Bommareddy, M.R. Middleton, Mohammed Milhem, J.J. Sacco, Judith Michels, G.K. In, D. Schadendorf, Georgia M. Beasley, J. Niu, Bartosz Chmielowski, T.M. Wise-Draper, Tawnya L. Bowles, Katy K. Tsai, C. Lebbé, C. Gaudy-Marqueste, Adel Samson, J.A. Chesney, Ari M. Vanderwalde, Marta Viana, Claudia Tucci, T. Liu, Laxminarasimha Donthireddy, Ana Monteagudo, Junhong Zhu, Jundi Hou, Michael K. Wong · 发表于：EJC Skin Cancer · 年份：2025 · DOI：10.1016/j.ejcskn.2025.100617 · 研究领域：Cancer Immunotherapy and Biomarkers、Cutaneous Melanoma Detection and Management、CAR-T cell therapy research